ت:    25332330
نقال: 90094424
2:00 الى 6:00 مساءا (أيام الإسبوع)
السبت 10:30 ص-1:30 م. الجمعة عطلة

NIH clinical trial testing antiviral remdesivir plus anti-inflammatory drug baricitinib for COVID-19 begins

08/05/2020

The trial is now enrolling hospitalized adults with COVID-19 in the United States.

Read More